His seminar, titled "Stem Cells Defects in Metabolic Syndrome and Role of Heme Oxygenase and Adiponectin in Insulin Resistance," will take place January 20, 2011, at 4 p.m. in the Medical Sciences Building auditorium on USA’s main campus.
Research programs in Dr. Abraham’s laboratory are focused on vascular dysfunction, which are a prelude to cardiovascular and metabolic diseases including hypertension, stroke, diabetes and obesity; the role of oxidative stress; inflammatory cytokines; and hypoadiponectinemia. One of the laboratory’s research approaches represents a powerful tool to identify therapeutic strategies and novel biomarkers for cardiovascular and metabolic diseases.
Dr. Abraham received his doctorate degree in biomedical sciences from Mt. Sinai School of Medicine in New York. He completed post-doctoral work in pharmacology/metabolism at Rockefeller Univeristy, also in New York. In 2009, Dr. Abraham received an honorary doctorate in pharmacy from the University of Catania in Sicily, Italy.
For more information on Dr. Abraham, visit http://www.utoledo.edu/med/depts/physpharm/faculty/abraham.html
For additional information on the lecture, contact Natalie Kent at (251) 461-1548.
